Featured Research

from universities, journals, and other organizations

HIV protein unveils vaccine target

Date:
April 1, 2011
Source:
University of California - Davis
Summary:
A new study describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet observed in nature. The finding could reveal new targets for vaccines to prevent HIV infection and AIDS.

This side view of the HIV envelope protein shows a virus (bottom) and a T cell (top). The mesh shows its normal shape, the green/red/blue shading shows its changed shape.
Credit: R. Holland Cheng/UC Davis graphic

An international study headed by a UC Davis scientist describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet observed in nature. The finding could reveal new targets for vaccines to prevent HIV infection and AIDS. A paper describing the work was published online in the Proceedings of the National Academy of Sciences.

Related Articles


In the new study, researchers from the U.S., Sweden and France explored the structure and behavior of the HIV envelope protein complex, which could potentially serve as a component of a vaccine aimed at eliciting the human immune system to generate antibodies against HIV.

"By opening up these less exposed regions, we might be able to raise more broadly cross-reactive antibodies to HIV," said R. Holland Cheng, professor of molecular and cellular biology at UC Davis and senior author of the study.

HIV infects a type of white blood cell called the CD4 T cell, weakening the immune system and leading to AIDS. HIV attaches to these cells through the envelope protein complex, which is made up of three gp120 proteins and three gp41 proteins, Cheng said.

First, the gp120 protein attaches to a CD4 protein on the victim cell's membrane. Then it uses gp41 to punch a hole through the membrane.

UC Davis graduate student Carlos Moscoso and project scientist Li Xing, working in Cheng's laboratory, used a cryoelectron microscope to study the structure of the complex and how it changes when it is exposed to a piece of the CD4 protein. A cryoelectron microscope derives three-dimensional images of complex protein structures from samples frozen in liquid nitrogen.

They found that when the HIV protein complex attaches to a CD4 protein, it rotates and flattens, exposing more of the gp41 proteins in the middle -- probably allowing the gp41 protein to get closer to the cell membrane so it can lock on.

It also potentially exposes an area of the virus that would be vulnerable to attack by the immune system, Cheng said. If a person were vaccinated and had antibodies to such a protein region, they might be able to stop the virus at the point of invading the CD4 T cell.

The gp120 protein itself varies considerably between strains, so it has been difficult to make an effective vaccine against it. But these hidden protein regions vary less between different strains of HIV, Cheng said.

Cheng's group is part of the HIV Research and Design consortium formed by the National Institutes of Health to pursue new targets for HIV vaccines. In future work, the consortium plans to test potent antibodies from HIV-positive people who have survived without developing AIDS to see if the antibodies recognize the new potential vaccine targets.

The envelope protein complex was prepared by Novartis Diagnostics and Vaccines Inc. of Cambridge, Mass.

The other authors of the paper are: Selina Poon, Dominik Green and Frank Lin at the Department of Molecular and Cellular Biology, UC Davis; Yide Sun, Elaine Kan, Susan Barnett and Indresh Srivastava, at Novartis; Loοc Martin, Commissariat ΰ l'Ιnergie Atomique, France; and Anders Vahlne, Karolinska Institute, Sweden.

The work was funded by the NIH.


Story Source:

The above story is based on materials provided by University of California - Davis. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. G. Moscoso, Y. Sun, S. Poon, L. Xing, E. Kan, L. Martin, D. Green, F. Lin, A. G. Vahlne, S. Barnett, I. Srivastava, R. H. Cheng. Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1016113108

Cite This Page:

University of California - Davis. "HIV protein unveils vaccine target." ScienceDaily. ScienceDaily, 1 April 2011. <www.sciencedaily.com/releases/2011/03/110331094626.htm>.
University of California - Davis. (2011, April 1). HIV protein unveils vaccine target. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2011/03/110331094626.htm
University of California - Davis. "HIV protein unveils vaccine target." ScienceDaily. www.sciencedaily.com/releases/2011/03/110331094626.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) — Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) — NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) — A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) — Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins